Newsfeeds - Spark Newswire

1 minute read

FDA
News

Heat Biologics 8-K Shows Co. Is Announcing Commencement Of Biosecurity/Biodefense Initiative To Be Initiated Via Its Blackhawk Bio Subsidiary

Today, 5:14 PM

Heat Biologics, Inc. (the “Company”) is announcing commencement of a biosecurity/biodefense initiative to be initiated via its Blackhawk Bio, Inc. subsidiary. The Company recognizes the need for a versatile

HTBX

10 minute read

Uncategorized

HTBX: Y’all Can Find me Down in San Antone

By Zacks Small Cap Research

Today, 5:14 PM

By John Vandermosten, CFA NASDAQ:HTBX READ THE FULL HTBX RESEARCH REPORT

HTBX

1 minute read

Heat Biologics Q2 EPS $(0.26) Up From $(0.35) YoY, Sales $459.49M Up From $593.16K YoY

By Benzinga Newsdesk

Today, 5:14 PM

Heat Biologics (NASDAQ:HTBX) reported quarterly losses of $(0.26) per share. This is a 25.71 percent increase over losses of $(0.35) per share from the same period last year. The company reported $459.49 million in

HTBX

1 minute read

News

Heat Biologics Announces Significant Expansion of R&D and Pre-Clinical Capabilities at Corporate Headquarters

By Benzinga Newsdesk

Today, 5:14 PM

Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product

HTBX